Aggressive progression of breast cancer with microscopic pulmonary emboli possessing a stem cell-like phenotype independent of its origin

Pathology International

Volumn 60, Issue 3, 2010, Pages 228-234

  Kawasaki, Hideya ^a   Ogura, Hiroyuki ^a   Arai, Yoshifumi ^a   Baba, Satoshi ^a   Kosugi, Isao ^a   Tsutsui, Yoshihiro ^a   Iwashita, Toshihide ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Embryonic stem cell marker; Pulmonary embolic breast cancer

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; CD133 ANTIGEN; CD24 ANTIGEN; CYTOKERATIN 5; CYTOKERATIN 6; DNA TOPOISOMERASE (ATP HYDROLYSING); ENDOXATHANE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; HERMES ANTIGEN; KI 67 ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; PROGESTERONE RECEPTOR; TOPOISOMERASE IIALPHA; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR NANOG2; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; UVOMORULIN;

ABDOMEN; ADULT; ARTICLE; AUTOPSY; BLOOD CLOT; BLOOD PH; BONE MARROW METASTASIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER STEM CELL; CARBON DIOXIDE TENSION; CASE REPORT; CELL RENEWAL; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DISEASE SEVERITY; DYSPNEA; EMBRYONIC STEM CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LIVER METASTASIS; LUNG EMBOLISM; LUNG METASTASIS; LUNG PERFUSION; LUNG VENTILATION; LYMPH NODE METASTASIS; MASTALGIA; OXYGEN TENSION; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESPIRATORY DISTRESS; THORAX WALL CANCER;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE PROGRESSION; DYSPNEA; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PULMONARY EMBOLISM; STEM CELLS;

EID: 77649145862     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2009.02502.x     Document Type: Article

References (31)

1. Marini JJ, Bilnoski W, Huseby JS. Acute cor pulmonale resulting from tumor microembolism. West J Med 1980 132 : 77 80.
2. Schriner RW, Ryu JH, Edwards WD. Microscopic pulmonary tumor embolism causing subacute cor pulmonale: A difficult antemortem diagnosis. Mayo Clin Proc 1991 66 : 143 148.
3. Lawson JC, Blatch GL, Edkins AL. Cancer stem cells in breast cancer and metastasis. Breast Cancer Res Treat 2009 118 : 241 254.
4. Ben-Porath I, Thomson MW, Carey VJ et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008 40 : 499 507.
5. Balic M, Lin H, Young L et al. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 2006 12 : 5615 5621.
6. Nielsen TO, Hsu FD, Jensen K et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004 10 : 5367 5374.
7. Schoenhals M, Kassambara A, De Vos J, Hose D, Moreaux J, Klein B. Embryonic stem cell markers expression in cancers. Biochem Biophys Res Commun 2009 383 : 157 162.
8. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003 100 : 3983 3988. (Pubitemid 36418143)
9. Ginestier C, Hur MH, Charafe-Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007 1 : 555 567.
10. Morimoto K, Kim SJ, Tanei T et al. Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression. Cancer Sci 2009 100 : 1062 1068.
11. Xiao Y, Ye Y, Yearsley K, Jones S, Barsky SH. The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype. Am J Pathol 2008 173 : 561 574.
12. Dent R, Hanna WM, Trudeau M, Rawlinson E, Sun P, Narod SA. Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res Treat 2009 115 : 423 428.
13. Reis-Filho JS, Tutt AN. Triple negative tumours: A critical review. Histopathology 2008 52 : 108 118.
14. Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO. Prognostic markers in triple-negative breast cancer. Cancer 2007 109 : 25 32.
15. Fan C, Oh DS, Wessels L et al. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 2006 355 : 560 569.
16. Herschkowitz JI, Simin K, Weigman VJ et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007 8 : R76.
17. Wright MH, Robles AI, Herschkowitz JI et al. Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1. Mol Cancer 2008 7 : 29.
18. Berner HS, Suo Z, Risberg B, Villman K, Karlsson MG, Nesland JM. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas. Histopathology 2003 42 : 546 554.
19. Glinsky GV. 'Stemness' genomics law governs clinical behavior of human cancer: Implications for decision making in disease management. J Clin Oncol 2008 26 : 2846 2853.
20. Glinsky GV. Stem cell origin of death-from-cancer phenotypes of human prostate and breast cancers. Stem Cell Rev 2007 3 : 79 93.
21. Ponti D, Costa A, Zaffaroni N et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005 65 : 5506 5511.
22. Bourguignon LY, Peyrollier K, Xia W, Gilad E. Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem 2008 283 : 17635 17651.
23. Alpaugh ML, Tomlinson JS, Shao ZM, Barsky SH. A novel human xenograft model of inflammatory breast cancer. Cancer Res 1999 59 : 5079 5084.
24. Fehm T, Hoffmann O, Aktas B et al. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells. Breast Cancer Res 2009 11 : R59.
25. Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res 2009 11 : R46.
26. Tomlinson JS, Alpaugh ML, Barsky SH. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res 2001 61 : 5231 5241.
27. Wicha MS, Liu S, Dontu G. Cancer stem cells: An old idea - a paradigm shift. Cancer Res 2006 66 : 1883 1890 discussion 1895 1896.
28. Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 2009 8 : 3274 3284.
29. Silvan U, Diez-Torre A, Arluzea J, Andrade R, Silio M, Arechaga J. Hypoxia and pluripotency in embryonic and embryonal carcinoma stem cell biology. Differentiation 2009 78 : 159 168.
30. Baum B, Settleman J, Quinlan MP. Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 2008 19 : 294 308.
31. Gupta PB, Onder TT, Jiang G et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009 138 : 645 659.